| Analysis | Metabolite Name | Measured Value | Units | GROUP_ID |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.1074 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.2783 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.3295 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.4863 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.6515 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 0.7099 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 1.2901 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 4.975 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 6.9851 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 9.5178 | Relative Abundance | GOS |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 14.5892 | Relative Abundance | CON |
| Reversed phase NEGATIVE ION MODE | palmitoleate (16:1n7) | 20.4178 | Relative Abundance | GOS |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|